Healthcare delivery

Lung health

Lung diseases such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma impact millions of people. Multiple determinants of health, including poverty, smoking, air pollution, and proximity to healthcare, contribute to poor lung outcomes and may act as barriers to detection, diagnosis, and guideline-based care.

We partner to close care gaps, through programmes such as the Lung Ambition Alliance and the International Respiratory Coalition.

Oncology

Worldwide, cancer causes around 10 million deaths each year. We see a future where cancer is no longer a cause of death and are committed to transforming outcomes for people living with cancer through innovative medicines, powerful collaborations and a purpose-driven team. One example is our Cancer Care Africa programme which focuses on creating a more robust cancer ecosystem through capacity building, screening and earlier diagnosis, patient empowerment and access to medicines. 

Cardiovascular, renal and metabolic diseases

Hundreds of millions of people worldwide live with cardiorenal diseases, like hypertension, diabetes and chronic kidney disease. We collaborate to combat the rising burden of these diseases through programmes that reach high-risk populations, strengthen the delivery of primary care and enhance access to medicines and guideline-based care. Our flagship Healthy Heart Africa Programme is active in nine countries and has been making an impact for over a decade.

Rare Disease

Living with a rare disease is inherently inequitable, with diagnosis taking about five years on average and fewer than 10% of rare diseases having approved treatments. We aim to transform the lives of those affected by shortening diagnosis times, improving access to care and treatment, and advocating for equitable health policies for rare diseases.